دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Glucksklee, the Quad, and High-Risk Myeloma.
Nooka, Ajay K. MD 1,; Kaufman, Jonathan L. MD 1,; Lonial, Sagar MD 1,,
doi : 10.1200/JCO.23.02017
Volume 42(1) pgs. 1-121 January 1, 2024
Metastasis-Directed Therapy: A Moving Target Advancing Progress Forward.
Deek, Matthew P. MD 1,; Tran, Phuoc T. MD, PhD 2,; Jabbour, Salma K. MD 1,
doi : 10.1200/JCO.23.01274
Redefining the Position of Hormonal Therapy in Endometrial Cancer in the Era of Molecular Classification.
Pijnenborg, Johanna M.A. MD, PhD 1,2,; van Weelden, Willem Jan MD, PhD 1,3; Reijnen, Casper MD, PhD 2,4; Xanthoulea, Sofia PhD 5; Romano, Andrea PhD 5
doi : 10.1200/JCO.23.00470
Long-Term Follow-Up of the Response-Adjusted Therapy for Advanced Hodgkin Lymphoma Trial.
Luminari, Stefano MD 1,2,; Fossa, Alexander MD 3,; Trotman, Judith MD 4,; Molin, Daniel MD 5,; d'Amore, Francesco MD 6; Enblad, Gunilla MD 7,; Berkahn, Leanne MD 8,; Barrington, Sally F. MD 9,; Radford, John MD 10,; Federico, Massimo MD 2; Kirkwood, Amy A. MSc 11,; Johnson, Peter W.M. MD 12,,
doi : 10.1200/JCO.23.01177
Long-Term Follow-Up of the Response-Adapted Intergroup EORTC/LYSA/FIL H10 Trial for Localized Hodgkin Lymphoma.
Federico, Massimo MD 1,; Fortpied, Catherine MSc 2; Stepanishyna, Yana MD, PhD 3; Gotti, Manuel MD 4; van der Maazen, Richard MD 5; Cristinelli, Caterina MD 6; Re, Alessandro MD 7,; Plattel, Wouter MD 8; Lazarovici, Julien MD 9,; Merli, Francesco MD 10,; Specht, Lena MD 11,; Schiano de Colella, Jean-Marc MD 12,; Hutchings, Martin MD 11,; Versari, Annibale MD 10,; Edeline, Veronique MD 13; Stamatoulas, Aspasia MD 14,; Girinsky, Theodore MD 15; Ricardi, Umberto MD 16; Aleman, Berthe MD 17,; Meulemans, Bart MSc 2; Tonino, Sanne MD 18,; Raemaekers, John MD 5; Andre, Marc MD 19,
doi : 10.1200/JCO.23.01745
Isatuximab, Carfilzomib, Lenalidomide, and Dexamethasone for the Treatment of High-Risk Newly Diagnosed Multiple Myeloma.
Leypoldt, Lisa B. MD 1,; Tichy, Diana PhD 2; Besemer, Britta MD 3,; Hanel, Mathias MD 4,; Raab, Marc S. MD 5,; Mann, Christoph MD 6,; Munder, Markus MD 7,; Reinhardt, Hans Christian MD 8,; Nogai, Axel MD 9,; Gorner, Martin MD 10; Ko, Yon-Dschun MD 11; de Wit, Maike MD 12,; Salwender, Hans MD 13,; Scheid, Christof MD 14,; Graeven, Ullrich MD, PhD 15,; Peceny, Rudolf MD 16,; Staib, Peter MD, PhD 17,; Dieing, Annette MD 18,; Einsele, Hermann MD 19,; Jauch, Anna PhD 20; Hundemer, Michael MD 21,; Zago, Manola PhD 22; Pozek, Ema MSc 2; Benner, Axel Dipl Stat 2; Bokemeyer, Carsten MD 1,; Goldschmidt, Hartmut MD 23,; Weisel, Katja C. MD 1,,
doi : 10.1200/JCO.23.01696
Prophylactic Radiation Therapy Versus Standard of Care for Patients With High-Risk Asymptomatic Bone Metastases: A Multicenter, Randomized Phase II Clinical Trial.
Gillespie, Erin F. MD, MPH 1,2,,; Yang, Joanna C. MD, MPH 1,3; Mathis, Noah J. BA 1; Marine, Catherine B. BA 1; White, Charlie MS 4; Zhang, Zhigang PhD 4; Barker, Christopher A. MD 1,; Kotecha, Rupesh MD 5,; McIntosh, Alyson MD 6; Vaynrub, Max MD 7,; Bartelstein, Meredith K. MD 7; Mitchell, Aaron MD, MPH 4,8,; Guttmann, David M. MD 1; Yerramilli, Divya MD, MBE 1; Higginson, Daniel S. MD 1,; Yamada, Yoshida J. MD 1,; Kohutek, Zachary A. MD 1,9; Powell, Simon N. MD, PhD 1,; Tsai, Jillian MD, PhD 1,10,; Yang, Jonathan T. MD, PhD 1,2,
doi : 10.1200/JCO.23.00753
Efficacy and Safety of Trastuzumab Deruxtecan in Patients With HER2-Expressing Solid Tumors: Primary Results From the DESTINY-PanTumor02 Phase II Trial.
Meric-Bernstam, Funda MD 1,,; Makker, Vicky MD 2,3,; Oaknin, Ana MD 4,; Oh, Do-Youn MD 5,; Banerjee, Susana PhD 6,; Gonzalez-Martin, Antonio MD 7,; Jung, Kyung Hae MD 8,; Lugowska, Iwona MD 9,; Manso, Luis MD 10,; Manzano, Aranzazu MD 11,; Melichar, Bohuslav MD 12,; Siena, Salvatore MD 13,; Stroyakovskiy, Daniil MD 14,; Fielding, Anitra MBChB 15,; Ma, Yan MSc 16,; Puvvada, Soham MD 15,; Shire, Norah PhD 15,; Lee, Jung-Yun MD 17,
doi : 10.1200/JCO.23.02005
Cost-Utility Analysis of Geriatric Assessment and Management in Older Adults With Cancer: Economic Evaluation Within 5C Trial.
Sahakyan, Yeva MSc, MD, MPH 1; Li, Qixuan MSc 2; Alibhai, Shabbir M.H. MSc, MD, FRCPC 3,4,5,; Puts, Martine RN, PhD 6; Yeretzian, Shant T. MD, MPH 7; Anwar, Mohammed R. MBBS, MSc 5,8; Brennenstuhl, Sarah PhD 6; McLean, Bianca MD 9; Strohschein, Fay RN, PhD 10,11; Tomlinson, George PhD 2,5,8,; Wills, Aria BSc 6; Abrahamyan, Lusine MD, PhD 1,5,8,
doi : 10.1200/JCO.23.00930
International Validation of the Immunoscore Biopsy in Patients With Rectal Cancer Managed by a Watch-and-Wait Strategy.
El Sissy, Carine MD, PhD 1,2,3,4; Kirilovsky, Amos PhD 1,2,3,4,; Lagorce Pages, Christine MD, PhD 1,2,3,4,5,; Marliot, Florence MSc 1,2,3,4; Custers, Petra A. MD 6,7; Dizdarevic, Edina MD 8,9; Sroussi, Marine MD 10,11; Castillo-Martin, Mireia MD, PhD 12; Haicheur, Nacilla MSc 1,2,3,4; Dermani, Mohamed BSc 1,2,3,4; Loche, Nicolas BSc 1,2,3,4; Buttard, Benedicte PhD 1,2,3; Musina, Ana Maria MD, PhD 13,14; Anitei, Maria Gabriela MD, PhD 14,15; van den Berg, Jose G. MD, PhD 16; Broeks, Annegien PhD 17; Iseas, Soledad MD, PhD 18; Coraglio, Mariana MD 18; Loria, Fernando Sanchez MD, PhD 19; Romero, Alfredo MD 20; Laurent-Puig, Pierre MD, PhD 21,22,; de Reynies, Aurelien PhD 23,24,; Fernandez, Laura M. MD 25; Karoui, Mehdi MD, PhD 26; Tougeron, David MD, PhD 27,; Vaccaro, Carlos A. MD, PhD 28; Santino, Juan P. MD, PhD 28,; Poulsen, Laurids Ostergaard MD, PhD 8,9; Lindebjerg, Jan MD 8,9; O'Connor, Juan Manuel MD, PhD 19,; Scripcariu, Viorel MD, PhD 14,15; Dimofte, Mihail-Gabriel MD, PhD 13,14; Gerard, Jean-Pierre MD, PhD 29,; Chalabi, Myriam MD, PhD 30,; Figueiredo, Nuno MD, PhD 25; Perez, Rodrigo O. MD, PhD 31,32,33,; Habr-Gama, Angelita MD, PhD 31,32,33; Galon, Jerome PhD 1,2,3,; Hansen, Torben Frostrup MD, PhD 8,9; Jensen, Lars Henrik MD, PhD 8,9,; Beets, Geerard MD, PhD 6,7; Zeitoun, Guy MD 1,2,3,4,; Pages, Franck MD, PhD 1,2,3,4,,
doi : 10.1200/JCO.23.00586
Prognostic Factors for Relapse in Patients With Clinical Stage I Testicular Seminoma: A Nationwide, Population-Based Cohort Study.
Wagner, Thomas MD 1,2,; Toft, Birgitte Gronkaer MD 2; Lauritsen, Jakob MD 1,; Bandak, Mikkel MD, DMSc 1; Christensen, Ib Jarle MSc 1; Engvad, Birte MD 3; Kreiberg, Michael MD, PhD 1; Agerbaek, Mads MD 4; Dysager, Lars MD 5,; Rosenvilde, Josephine Julie MD 1; Berney, Daniel MB B Chir, MA, FRCPath 6; Daugaard, Gedske MD, DMSc 1,
doi : 10.1200/JCO.23.00959
Eflornithine as Postimmunotherapy Maintenance in High-Risk Neuroblastoma: Externally Controlled, Propensity Score-Matched Survival Outcome Comparisons.
Oesterheld, Javier MD 1,; Ferguson, William MD 2; Kraveka, Jacqueline M. DO 3,4,; Bergendahl, Genevieve MSN 5; Clinch, Thomas BS 6; Lorenzi, Elizabeth PhD 7; Berry, Don PhD 7,8,; Wada, Randal K. MD 9; Isakoff, Michael S. MD 10,11; Eslin, Don E. MD 12; Brown, Valerie I. MD, PhD 5; Roberts, William MD 13,14; Zage, Peter MD, PhD 13,14,; Harrod, Virginia L. MD, PhD 15; Mitchell, Deanna S. MD 16; Hanson, Derek MD 17; Saulnier Sholler, Giselle L. MD, MSc 5,,
doi : 10.1200/JCO.22.02875
Application of Metabolomics to Epidemiologic Studies of Breast Cancer: New Perspectives for Etiology and Prevention.
His, Mathilde PhD 1,2,3; Gunter, Marc J. PhD 1,4; Keski-Rahkonen, Pekka PhD 1; Rinaldi, Sabina PhD 1,
doi : 10.1200/JCO.22.02754
Pathways Involved in the Effect of Eflornithine in Neuroblastoma.
Wolpaw, Adam J. MD, PhD 1; Dang, Chi V. MD, PhD 2,3,4,5,6,,
doi : 10.1200/JCO.23.01783
Understanding Tradeoffs in the Treatment of Rectal Cancer From the Patient Perspective.
Dossa, Fahima MD, PhD; Baxter, Nancy N. MD, PhD
doi : 10.1200/JCO.23.01469
Reply to F. Dossa et al.
Basch, Ethan MD; Dueck, Amylou PhD; Weiser, Martin MD; Schrag, Deborah MD
doi : 10.1200/JCO.23.01640
